Research Peptide
Retatrutide
Triple agonist peptide
$90/ 10mg vialSold Out
Select size
Retatrutide is an investigational "triple agonist" peptide that targets GLP-1, GIP, and glucagon receptors to support weight loss, appetite control, and metabolic function. Early clinical trials have shown significant fat loss and improved blood sugar regulation, making it one of the most promising next-generation obesity therapies currently in development.
For Research Use Only · Not for human or veterinary consumption
1
- Gold
- Standard
- Research
- Grade
- Premium
- Quality